HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Pfleger, A. Articles by Zach, M.S. Search for Related Content PubMed PubMed Citation Articles by Pfleger, A. Articles by Zach, M.S.

Effects of nedocromil and salbutamol on airway reactivity in children with asthma

Respiratory and Allergic Disease Division, Paediatric Dept, University of Graz, Graz, Austria

CORRESPONDENCE: A. Pfleger, Klinische Abteilung für Pädiatrische Pulmonologie und Allergologie, Univ.-Klinik für Kinder-und Jugendheilkunde, Auenbruggerplatz 30, A-8036, Graz, Austria. Fax: 43 3163853276. E-mail: andreas.pfleger@kfunigraz.ac.at

Keywords: exercise-induced asthma, cold dry air challenge, nedocromil, preventive effect, salbutamol

Received: January 28, 2002
Accepted April 16, 2002

This study was supported by grant TIL-AT 601 from Rhône Poulenc Rorer.

Nedocromil and salbutamol are effective drugs in preventing exercise-induced asthma (EIA). The aim of this study was to compare the protective effects of both drugs and a combination of both drugs against cold dry air-induced bronchoconstriction, using cold dry air challenges (CACh) as a surrogate for exercise.

Twenty-five atopic children (mean age 13.7, range 8–18 yrs) with EIA participated in the study. Lung function tests were performed before medication, 30 min after medication and just before CACh, and 3 and 15 min after the challenge on four consecutive days. CACh consisted of a 4-min isocapnic hyperpnoea of –10°C, absolutely dry air. Treatment consisted of nedocromil (two puffs of 2 mg) plus placebo, salbutamol (two puffs of 100 µg) plus placebo, the combination of both drugs, and placebo alone, in a random order.

Both active drugs were significantly more protective than placebo and the combination showed an additive effect. Mean maximum postchallenge decrease in forced expiratory volume in one second after placebo was 27±8.1%, 12±9.5% after nedocromil, 8±10.4% after salbutamol, and 4.5±6.7% after the combination of both drugs, respectively.

These results suggest that both drugs protect against exercise-induced asthma. Although not as effective as salbutamol and combined medication, nedocromil can give sufficient protection for many patients.

This article has been cited by other articles:

				F. Fanfulla, M. Delmastro, A. Berardinelli, N. D. Lupo, and S. Nava Effects of Different Ventilator Settings on Sleep and Inspiratory Effort in Patients with Neuromuscular Disease Am. J. Respir. Crit. Care Med., September 1, 2005; 172(5): 619 - 624. [Abstract] [Full Text] [PDF]